Report #2873421

Received Nov 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: KY
Recovered: Unknown
Vaccinated: Nov 12, 2025
Onset: Nov 12, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
FLU3	INFLUENZA (SEASONAL) (FLULAVAL)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	—

Symptoms (1)

Expired product administered

Symptom narrative

female patient received an expired dose of Flulaval.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 53-year-old female patient who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) (expiry date 30-JUN-2025) for prophylaxis. On 12-NOV-2025, the patient received FluLaval 2024-2025 season. On 12-NOV-2025, an unknown time after receiving FluLaval 2024-2025 season, the patient experienced expired vaccine used (Verbatim: female patient received an expired dose of Flulaval.). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 13-NOV-2025 The reporter wants to be asked when have to revaccinate the patient. The reporter was consented to follow up.